Last update of the site: June 6th, 2025
Daghistani Hussam 1 et al. | Lipids in Health and Disease
Abstract Long noncoding RNAs (lncRNAs) have emerged as critical regulators of lipid metabolism, playing pivotal roles in cholesterol biosynthesis, transport,
Tassew Worku Chekol 1 et al. | BMC Cardiovascular Disorders
Abstract Introduction Dyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant
Yang Ningjing 1 et al. | Lipids in Health and Disease
Abstract Background Primary healthcare (PHC) plays a key role in hyperlipidemia (HL) management yet lacks adequate monitoring and feedback. This
Tassew Worku Chekol 1 et al. | BMC Cardiovascular Disorders
Abstract Introduction Dyslipidemia and other CVD risk factors in cardiac patients can lead to accelerated atherosclerosis, morbidity, and significant
Yang Ningjing 1 et al. | Lipids in Health and Disease
Abstract Background Primary healthcare (PHC) plays a key role in hyperlipidemia (HL) management yet lacks adequate monitoring and feedback. This
Yang QianKun 1 et al. | Cardiovascular Diabetology
Abstract Background Dyslipidemia has been proved to play a pivotal role in biological aging. Atherogenic Index of Plasma (AIP), derived
Koohi Fatemeh 1 et al. | Journal of Translational Medicine
Abstract Background Understanding the distinct patterns (trajectories) of variation in blood lipid levels before diagnosing cardiovascular disease (CVD) might carry
Wang Yihan 1 et al. | BMC Cardiovascular Disorders
Abstract Background Familial hypercholesterolemia (FH) is a genetically inherited disorder caused by monogenic mutations or polygenic deleterious variants. Patients with
